Clinical trials of Covaxin for children from two and 18 years has been cleared by the Drugs Controller General of India (DCGI). Covaxin maker Bharat Biotech has said the trial will be carried out on “525 healthy volunteers”. According to a government statement, the drug regulator accepted the recommendation of an expert committee on vaccines. The trial involves two vaccine… Continue reading "DCGI approves clinical trials of Covaxin for children from 0 to 18 years"
The post DCGI approves clinical trials of Covaxin for children from 0 to 18 years appeared first on Tamil Nadu News, Chennai News, Tamil Cinema News, Tamil News, Tamil Movie News, Power Shutdown in Chennai, Petrol and Diesel Rate in Chennai.
Tags
News